Abstract:Study design: An open- label, multicentre study was conducted to evaluate the antihypertensive efficacy of a 4-week course of losartan 50 mg plus hydrochlorothiazide 12.5 mg in Asian patients with essential hypertension whose blood pressure had previously been treated with but not controlled by valsartan 80 mg.Methods: A total of 237 eligible patients with mean trough sitting diastolic blood pressure SiDBP) 95 - 115 mmHg and a mean trough sitting systolic blood pressure ( SiSBP) < 190 mmHg entered the baseline period of treatment with valsartan 80 mg/ day for 4 weeks. Those ( n = 165) whose SiDBP remained > 90 mmHg and who were not excluded for other reasons were then switched to a single-tablet formulation of losartan 50 mg/ hydrochlorothiazide 12.5 mg combination once daily for a further 4 weeks.Results: Mean SiDBP ( study primary endpoint) at the end of combination therapy was reduced to 86.9 mmHg from 95.2 mmHg. SiSBP ( study secondary endpoint) was reduced to 132.6 mmHg from 140.7 mmHg. Mean reductions after switching from valsartan 80 mg to losartan 50 mg/hydrochlorothiazide 12.5 mg were thus 8.3 and 8.1 mmHg for SiDBP and SiSBP, respectively ( p <= 0.001 for both outcomes). The goal of SiDBP <= 90 mmHg was attained in 72% of the patients previously not controlled to the same level by valsartan 80 mg/day. Combination therapy with losartan 50 mg/hydrochlorothiazide 12.5 mg was generally well tolerated. Mean compliance with the losartan 50 mg/hydrochlorothiazide 12.5 mg combination was > 99%.Conclusion: These results demonstrate that in Asian patients who do not reach the goal of mean trough SiDBP <= 90 mmHg with valsartan monotherapy at 80 mg once-daily, switching to a single-tablet combination of losartan 50 mg/hydrochlorothiazide 12.5 mg once-daily is well tolerated, provides effective control of blood pressure and is an excellent choice to achieve blood pressure reduction goals.

Valsartan/Amlodipine in the Treatment of 102 Cases of Resistant Hypertension

The Clinical Efficacy and Safety of Valsartan in Treatment of Patients with Essential Hypertensive

Effect of Valsartan on the Level of Vwf in Patients with Hypertension and Metabolic Syndrome

Efficacy and Safety of the Compound of Candesartan Cilexetial and Hydrochlorothiazide in Patients with Essential Hypertension

Clinical observation of sacubitril valsartan sodium in the treatment of resistant hypertension: A randomized clinical trial

Effects of Compound Valsartan in Patients with Mild to Moderate Essential Hypertension

[A Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 80 Mg in Chinese Hypertensive Patients Who Failed to Respond Adequately to Telmisartan 80 Mg].

Clinical Study of Olmesartan/hydrochlorothiazide Compound Tablet in Mild to Moderate Essential Hypertensive Patients Who Did Not Reach Goal with Olmesartan

Amlodipine/valsartan 5/160mg Versus Valsartan 160mg in Chinese Hypertensives

Effect of combining valsartan and amlodipine in the treatment of type 2 diabetes mellitus complicated by hypertension

Influence of valsartan on Microalbuminuria of Essential Hypertensive Patients

G-002 AMLODIPINE/VALSARTAN 5/160 MG VERSUS VALSARTAN 160 MG IN PREDOMINANTLY CHINESE PATIENTS WITH STAGE 1 OR 2 ESSENTIAL HYPERTENSION NOT ADEQUATELY CONTROLLED ON VALSARTAN 160 MG MONOTHERAPY

Therapeutic Efficacy of Valsartan and Valsartan/hctz in Mild to Moderate Hypertensive Patients

Efficacy and Tolerability of Once-Daily 160 Mg Valsartan in Chinese Patients with Mild to Moderate Hypertension.

Effect of telmisartan on microalbuminuria in patients with hypertension

Efficacy and Safety of Olmesartan Medoxomil-Amlodipine Besylate Tablet in Chinese Patients with Essential Hypertension: A Prospective, Single-Arm, Multi-Center, Real-World Study

Effect on Blood Pressure Control of Switching from Valsartan Monotherapy to Losartan/hydrochlorothiazide in Asian Patients with Hypertension: Results of a Multicentre Open-Label Trial

Effect of valsartan on chronotropic incompetence in hypertensive patients complicated with type 2 diabetes mellitus

Effect of Valsartan on Elderly Hypertension

Clinical effect and safety of nifedipine controlled-release tablets combined with valsartan in the treatment of primary hypertension

Efficacy and tolerability of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients not adequately controlled with valsartan monotherapy.